Search

everythinglearnresearchcommunity

for

Search:↓

Taking Kera-Diet® improves hair and nail health without side effects.

Polymeric micelle nanocarriers deliver adapalene more effectively to hair follicles than commercial products.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

Multicomponent crystals in microneedles improve drug delivery for hair loss treatment.

The scaffolds significantly sped up wound healing in dogs and were safe.

Researchers developed a new skin patch that delivers more finasteride into the skin, potentially improving treatment for hair loss and prostate issues.

The UK High Court revoked Lundbeck's patent for Escitalopram, and second medical use claims based on dosage were not considered novel.

Improved tablets lead to faster, better drug absorption for hair loss treatment.

Method accurately measures finasteride concentration in medicine.

Improved finasteride formula allows slow, sustained release and better absorption for patients.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Companies agreed to stop making false health claims about their products.

Keratin-gelatin films improve skin graft success in dogs.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

The new clinical trial design is promising but needs real-world trials to test its effectiveness and possible enhancements.

Baricitinib and tofacitinib have different safety patterns in treating alopecia areata.

Finasteride helps female-pattern hair loss.

UK courts and the European Patent Office are now more open to granting patents for new dosage regimes.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Nanoparticles show potential for controlled release of hair loss drugs, improving treatment effectiveness.

Patients prefer the higher 50 mg dose of ritlecitinib for better hair regrowth despite higher risks.

Standard nail varnish effectively prevents follicular penetration of certain substances.

Ketoconazole loaded solid lipid nanoparticles can penetrate skin better than regular drug suspension and marketed product, providing slow, sustained release and improved stability.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.